REFERENCES
- Nussenblatt RB, Mittal KK, Ryan S, Green WR, Maumenee AE. Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol. 1982;94:147–158.
- Levinson RD, Brézin AP, Rothova A, Accorinti M, Holland GN. Research criteria for the diagnosis of birdshot chorioretinopathy: results of an international consensus conference. Am J Ophthalmol. 2006;141:185–187.
- Shah KH, Levinson RD, Yu F, et al. Birdshot chorioretinopathy. Surv Ophthalmol. 2005;50:519–541.
- Wender JD, Fu AD, Jumper JM, McDonald HR, Johnson RN, Cunningham ET Jr. False negative antibody-based HLA-A29 typing in two patients with birdshot chorioretinopathy. Br J Ophthalmol. 2008;92:1153–1154.
- Priem HA, Kijlstra A, Noens L, Baarsma GS, De Laey JJ, Oosterhuis JA. HLA typing in birdshot chorioretinopathy. Am J Ophthalmol. 1988;105:182–185.
- Jakob E, Reuland MS, Mackensen F, et al. Uveitis subtypes in a German interdisciplinary uveitis center-analysis of 1916 patients. J Rheumatol. 2009;36:127–136.
- McCannel CA, Holland GN, Helm CJ, Cornell PJ, Winston JV, Rimmer TG. Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol. 1996;121:35–46.
- Gasch AT, Smith JA, Whitcup SM. Birdshot retinochoroidopathy. Br J Ophthalmol. 1999;83:241–249.
- Barondes MJ, Fastenberg DM, Schwartz PL, Rosen DA. Peripheral retinal neovascularization in birdshot retinochoroidopathy. Ann Ophthalmol. 1989;21:306–308.
- Saito W, Yamamoto S, Mitamura Y, Takeuchi S. Birdshot chorioretinopathy: a case report and a case study in Japanese patients. Nippon Ganka Gakkai Zasshi. 2002;106:229–235.
- Fich M, Rosenberg T. Birdshot retinochoroidopathy in monozygotic twins. Acta Ophthalmol. 1992;70:693–697.
- Trinh L, Bodaghi B, Fardeau C, et al. Clinical features, treatment methods, and evolution of birdshot chorioretinopathy in 5 different families. Am J Ophthalmol. 2009;147:1042–7.
- Donvito B, Monnet D, Tabary T, et al. Different HLA class IA region complotypes for HLA-A29.2 and -A29.1 antigens, identical in birdshot retinochoroidopathy patients or healthy individuals. Invest Ophthalmol Vis Sci. 2005;46:3227–3232.
- Wee R, Papaliodis G. Genetics of birdshot chorioretinopathy. Semin Ophthalmol. 2008;23:53–57.
- Levinson RD, Rajalingam R, Park MS, et al. Human leukocyte antigen A29 subtypes associated with birdshot retinochoroidopathy. Am J Ophthalmol. 2004;138:631–634.
- Donvito B, Monnet D, Tabary T, et al. A new HLA extended haplotype containing the A*2910 allele is also associated with birdshot retinochoroidopathy and narrows susceptibility to the disease to the HLA molecule itself. Invest Ophthalmol Vis Sci. 2010;51:2525–2528.
- Szpak Y, Vieville JC, Tabary T, et al. Spontaneous retinopathy in HLA-A29 transgenic mice. Proc Natl Acad Sci USA. 2001;98:2572–2576.
- de Kozak Y, Camelo S, Pla M. Pathological aspects of spontaneous uveitis and retinopathy in HLA-A29 transgenic mice and in animal models of retinal autoimmunity: relevance to human pathologies. Ophthalmic Res. 2008;40:175–180.
- Boisgerault F, Khalil I, Tieng V, et al. Definition of the HLA-A29 peptide ligand motif allows prediction of potential T-cell epitopes from the retinal soluble antigen, a candidate autoantigen in birdshot retinopathy. Proc Natl Acad Sci USA. 1996 16;93:3466–3470.
- Levinson RD, Du Z, Luo L, et al. Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals. Genes Immun. 2008;9:249–258.
- Gaudio PA, Kaye DB, Crawford JB. Histopathology of birdshot retinochoroidopathy. Br J Ophthalmol. 2002;86:1439–1441.